Three-year OCT predictive factors of disease recurrence in eyes with successfully treated myopic choroidal neovascularisation

医学 眼科 视力 回顾性队列研究 人口统计学的 队列 黄斑变性 眼病 外科 内科学 人口学 社会学
作者
Enrico Borrelli,Marco Battista,Giovanna Vella,Riccardo Sacconi,Lea Querques,Domenico Grosso,Francesco Bandello,Giuseppe Querques
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:: bjophthalmol-318440
标识
DOI:10.1136/bjophthalmol-2020-318440
摘要

To assess the relationship of demographics, clinical characteristics and structural optical coherence tomography (OCT) findings to disease recurrence in a cohort of patients with newly diagnosed myopic choroidal neovascularisation (CNV) METHODS: In this retrospective, longitudinal study, a total of 64 participants (64 eyes) with successfully treated myopic CNV had obtained resolution of exudation after treatment (study baseline) and with 3 years of regular follow-ups. Several baseline OCT qualitative features and quantitative measurements were assessed at baseline and included in the analysis. Main outcome measures included incidence of disease recurrence and HR for demographics, clinical characteristics and OCT risk factors.At month 36, 40 eyes (62.5%) developed disease recurrence (active CNV). Multivariate linear regression analysis revealed that final visual acuity (dependent variable) was associated with visual acuity at the first visit after complete resolution of exudation (p<0.0001), baseline size of patchy atrophy (p=0.010), baseline subfoveal choroidal thickness (p=0.008), baseline maximum CNV height and width (p=0.011 and p=0.003) and recurrence of CNV exudation (p=0.007). The following factors were associated with an increased risk of disease recurrence: size of patchy atrophy had an HR of 1.14 (95% CI 1.01 to 1.29; p=0.036); maximum CNV width had an HR of 1.02 (95% CI 1.01 to 1.04; p<0.0001).We identified OCT risk factors for the disease recurrence in eyes with successfully treated myopic CNV. Assuming that disease recurrence is a sight-threatening event, our findings may help in the identification of high-risk patients and eventually ameliorate their outcome.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一衣完成签到,获得积分20
刚刚
刚刚
2秒前
明理世倌发布了新的文献求助10
2秒前
今后应助niu1采纳,获得10
3秒前
KONG发布了新的文献求助10
3秒前
爆米花应助成梦采纳,获得10
3秒前
yhl完成签到,获得积分20
4秒前
皮皮发布了新的文献求助10
5秒前
圆圆的脑袋应助SCISSH采纳,获得10
6秒前
阳光的雁山完成签到,获得积分10
6秒前
霖宸羽完成签到,获得积分10
7秒前
9秒前
无奈的代珊完成签到 ,获得积分10
9秒前
10秒前
10秒前
搜集达人应助糊涂的小伙采纳,获得10
10秒前
mmd完成签到 ,获得积分10
11秒前
11秒前
Lily完成签到,获得积分10
12秒前
温言发布了新的文献求助10
13秒前
13秒前
Roy完成签到,获得积分10
13秒前
永远少年完成签到,获得积分10
15秒前
niu1发布了新的文献求助10
15秒前
16秒前
Danny完成签到,获得积分10
16秒前
Lsx完成签到 ,获得积分10
16秒前
又胖了发布了新的文献求助10
17秒前
17秒前
小小飞发布了新的文献求助20
18秒前
18秒前
18秒前
19秒前
wanci应助NorthWang采纳,获得10
19秒前
zhen完成签到,获得积分10
21秒前
ns发布了新的文献求助30
22秒前
23秒前
逐风完成签到,获得积分10
23秒前
无奈的酒窝完成签到,获得积分10
24秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527928
求助须知:如何正确求助?哪些是违规求助? 3108040
关于积分的说明 9287614
捐赠科研通 2805836
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709808